Close
Nordic 9Nordic 9

Ampersand Capital Partners (investor - Private Equity)

United States ampersandcapital.com
See something wrong or missing? Let us know
Offices:Boston, Amsterdam

Ampersand is a middle market private equity firm dedicated to growth-oriented investments in the healthcare sector, with offices in Boston and Amsterdam and founded in 1988.

Average round investment:N/A USD
Average number per year:0.0
Distribution: 2020 (1)
Portfolio companies: Germany GeneWerk GmbH
Mostly invests in: Germany Germany (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Ampersand Capital Partners

Name Criteria
Sweden Colibri Ventures
58%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
United States Decheng Capital
58%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Switzerland Endeavour Vision
58%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
IDO Investments
58%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
United States Longitude Capital
58%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Spain Plastigaur
58%
  • Range for average deal size: n/a USD
  • Similar verticals: Biotech, Health services
  • Similar business models: B2B
  • Active last 12 months: Yes
Germany Agaplesion
52%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Active last 12 months: Yes
Germany Alan Poensgen
52%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Active last 12 months: Yes
Germany Andreas Schneider
52%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Active last 12 months: Yes
Germany Athenion GmbH
52%
  • Range for average deal size: n/a USD
  • Similar verticals: Health services
  • Similar business models: B2B
  • Common investees countries: Germany
  • Active last 12 months: Yes
Top